BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 19640802)

  • 21. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
    Mingrone G
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass.
    Penniston KL; Kaplon DM; Gould JC; Nakada SY
    J Urol; 2009 Nov; 182(5):2340-6. PubMed ID: 19762051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 23-hour stay outcomes for laparoscopic Roux-en-Y gastric bypass in a small, teaching community hospital.
    Fares LG; Reeder RC; Bock J; Batezel V
    Am Surg; 2008 Dec; 74(12):1206-10. PubMed ID: 19097539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.
    Ott K; Bader FG; Lordick F; Feith M; Bartels H; Siewert JR
    Ann Surg Oncol; 2009 Apr; 16(4):1017-25. PubMed ID: 19189186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative upper gastrointestinal endoscopy in obese patients undergoing bariatric surgery: is it necessary?
    de Moura Almeida A; Cotrim HP; Santos AS; Bitencourt AG; Barbosa DB; Lobo AP; Rios A; Alves E
    Surg Obes Relat Dis; 2008; 4(2):144-9; discussion 150-1. PubMed ID: 18294926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of Roux-en-Y gastric bypass in morbidly obese vs superobese patients: similar body weight loss, correction of comorbidities, and improvement of quality of life.
    Suter M; Calmes JM; Paroz A; Romy S; Giusti V
    Arch Surg; 2009 Apr; 144(4):312-8; discussion 318. PubMed ID: 19380643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric bypass surgery in a paraplegic morbidly obese patient.
    Alaedeen DI; Jasper J
    Obes Surg; 2006 Aug; 16(8):1107-8. PubMed ID: 16901370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphincter of Oddi dysfunction after Roux-en-Y gastric bypass.
    Morgan KA; Glenn JB; Byrne TK; Adams DB
    Surg Obes Relat Dis; 2009; 5(5):571-5. PubMed ID: 19356993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally Invasive Ivor-Lewis Esophagectomy for Esophageal Cancer After Gastric Bypass.
    Latzko M; Ahmed B; Awad Z
    Ann Surg Oncol; 2021 Jan; 28(1):203. PubMed ID: 32488514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set.
    Ertelt TW; Mitchell JE; Lancaster K; Crosby RD; Steffen KJ; Marino JM
    Surg Obes Relat Dis; 2008; 4(5):647-50. PubMed ID: 18420465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging after bariatric surgery for morbid obesity: Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding.
    Carucci LR; Turner MA
    Semin Roentgenol; 2009 Oct; 44(4):283-96. PubMed ID: 19715793
    [No Abstract]   [Full Text] [Related]  

  • 32. Adenocarcinoma of the gastric pouch after Roux-en-Y gastric bypass: a new technique for en bloc resection and reconstruction.
    van de Vrande S; Himpens J; Leman G
    Surg Obes Relat Dis; 2017 Oct; 13(10):1793-1795. PubMed ID: 28780047
    [No Abstract]   [Full Text] [Related]  

  • 33. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach.
    Watkins BJ; Blackmun S; Kuehner ME
    Surg Obes Relat Dis; 2007; 3(6):644-7. PubMed ID: 17950044
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of weight regain after gastric bypass surgery when using a new endoscopic platform: initial experience and early outcomes (with video).
    Mullady DK; Lautz DB; Thompson CC
    Gastrointest Endosc; 2009 Sep; 70(3):440-4. PubMed ID: 19555944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass.
    Kellogg TA; Swan T; Leslie DA; Buchwald H; Ikramuddin S
    Surg Obes Relat Dis; 2009; 5(4):416-23. PubMed ID: 19540169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esophageal carcinoma following bariatric procedures.
    Allen JW; Leeman MF; Richardson JD
    JSLS; 2004; 8(4):372-5. PubMed ID: 15554284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
    Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does bariatric surgery decrease gastric cancer risk?
    Menéndez P; Padilla D; Villarejo P; Menéndez JM; Lora D
    Hepatogastroenterology; 2012; 59(114):409-12. PubMed ID: 22353507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Report of two cases of gastric cancer after bariatric surgery: lymphoma of the bypassed stomach after Roux-en-Y gastric bypass and gastrointestinal stromal tumor (GIST) after vertical banded gastroplasty.
    de Roover A; Detry O; de Leval L; Coimbra C; Desaive C; Honoré P; Meurisse M
    Obes Surg; 2006 Jul; 16(7):928-31. PubMed ID: 16839496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients.
    Serpa Neto A; Bianco Rossi FM; Dal Moro Amarante R; Alves Buriti N; Cunha Barbosa Saheb G; Rossi M
    J Nephrol; 2009; 22(5):637-46. PubMed ID: 19809997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.